TD Asset Management Inc Cuts Position in Bruker Corporation $BRKR

TD Asset Management Inc decreased its holdings in shares of Bruker Corporation (NASDAQ:BRKR) by 49.6% in the fourth quarter, Holdings Channel.com reports. The firm owned 215,398 shares of the medical research company’s stock after selling 211,800 shares during the period. TD Asset Management Inc’s holdings in Bruker were worth $10,147,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Allworth Financial LP increased its position in Bruker by 40.6% during the 3rd quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock valued at $29,000 after buying an additional 257 shares in the last quarter. Covestor Ltd boosted its holdings in Bruker by 304.6% in the fourth quarter. Covestor Ltd now owns 1,416 shares of the medical research company’s stock worth $67,000 after acquiring an additional 1,066 shares in the last quarter. CWM LLC grew its stake in shares of Bruker by 49.8% in the fourth quarter. CWM LLC now owns 1,631 shares of the medical research company’s stock worth $77,000 after acquiring an additional 542 shares during the last quarter. Eurizon Capital SGR S.p.A. bought a new position in shares of Bruker during the fourth quarter valued at $117,000. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Bruker by 51.5% during the second quarter. EverSource Wealth Advisors LLC now owns 2,770 shares of the medical research company’s stock valued at $114,000 after acquiring an additional 942 shares in the last quarter. 79.52% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

BRKR has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Bruker from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Guggenheim cut their price target on shares of Bruker from $58.00 to $50.00 and set a “buy” rating on the stock in a report on Monday, March 30th. TD Cowen raised their price target on shares of Bruker from $43.00 to $45.00 and gave the company a “hold” rating in a research report on Thursday, May 7th. The Goldman Sachs Group decreased their price objective on shares of Bruker from $40.00 to $35.00 and set a “sell” rating for the company in a report on Friday, February 13th. Finally, Wolfe Research started coverage on Bruker in a research note on Monday, June 1st. They set a “peer perform” rating on the stock. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $51.31.

Bruker Stock Performance

Shares of NASDAQ BRKR opened at $57.24 on Wednesday. The firm’s 50-day moving average price is $43.46 and its 200-day moving average price is $43.66. Bruker Corporation has a 52-week low of $28.53 and a 52-week high of $64.54. The company has a market cap of $8.71 billion, a PE ratio of -238.50, a PEG ratio of 1.80 and a beta of 1.31. The company has a quick ratio of 0.72, a current ratio of 1.55 and a debt-to-equity ratio of 0.67.

Bruker (NASDAQ:BRKR) last released its quarterly earnings data on Wednesday, May 6th. The medical research company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.08. Bruker had a negative net margin of 0.65% and a positive return on equity of 11.60%. The firm had revenue of $823.40 million during the quarter, compared to analysts’ expectations of $795.62 million. During the same period in the previous year, the company earned $0.47 earnings per share. The firm’s quarterly revenue was up 2.7% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, analysts anticipate that Bruker Corporation will post 2.12 EPS for the current year.

Bruker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 7th. Stockholders of record on Monday, June 22nd will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, June 22nd. Bruker’s dividend payout ratio is presently -83.33%.

Insider Buying and Selling at Bruker

In other news, VP Mark Munch sold 2,000 shares of the firm’s stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $39.90, for a total value of $79,800.00. Following the transaction, the vice president directly owned 128,443 shares in the company, valued at $5,124,875.70. This trade represents a 1.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. 27.20% of the stock is owned by insiders.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.